Tregs are regulated by cytokines: Implications for autoimmunity

Autoimmunity Reviews

Volumn 8, Issue 1, 2008, Pages 83-87

  La Cava, Antonio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Regulatory T cells; Systemic lupus erythematosus (SLE)

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 28; INTERLEUKIN 29; INTERLEUKIN 35; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CELLULAR IMMUNITY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NONHUMAN; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; TH3 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 54549111173     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.08.002     Document Type: Review

References (40)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
2. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
3. Mantovani A., Garlanda C., Locati M., Rodriguez T.V., Feo S.G., Savino B., et al. Regulatory pathways in inflammation. Autoimmun Rev 7 (2007) 8-11
4. Lan R.Y., Mackay I.R., and Gershwin M.E. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29 (2007) 272-280
5. Rizzi M., Ferrera F., Filaci G., and Indiveri F. Disruption of immunological tolerance: role of AIRE gene in autoimmunity. Autoimmun Rev 5 (2006) 145-147
6. Milner J., Ward J., Keane-Myers A., Min B., and Paul W.E. Repertoire-dependent immunopathology. J Autoimmun 29 (2007) 257-261
7. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., and Alt F.W. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 (1995) 521-530
8. Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94 (1997) 3168-3171
9. Aoki C.A., Roifman C.M., Lian Z.X., Bowlus C.L., Norman G.L., Shoenfeld Y., et al. IL-2 receptor α deficiency and features of primary biliary cirrhosis. J Autoimmun 27 (2006) 50-53
10. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FoxP3. Nat Genet 27 (2001) 20-21
11. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
12. + regulatory T cells. J Exp Med 201 (2005) 1061-1067
13. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441 (2006) 235-238
14. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory Th17 cells. Nature 448 (2007) 484-487
15. + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6. J Immunol 180 (2008) 7112-7116
16. Wan S., Xia C., and Morel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol 178 (2007) 271-279
17. Verrecchia F., Mauviel A., and Farge D. Transforming growth factor-β signaling through the Smad proteins: role in systemic sclerosis. Autoimmun Rev 5 (2006) 563-569
18. + T cells. J Immunol 173 (2004) 6526-6531
19. Zorn E., Nelson E.A., Mohseni M., Porcheray F., Kim H., Litsa D., et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT dependent mechanism and induces the expansion of these cells in vivo. Blood 108 (2006) 1571-1579
20. + regulatory T cells. Front Biosci 13 (2008) 1440-1446
21. - T cells. J Leukoc Biol 84 (2008) 480-487
22. + effector T cells. J Immunol 176 (2006) 7278-7287
23. hi T-regulatory cells. Blood 108 (2006) 253-261
24. + T regulatory cells. J Immunol 179 (2007) 154-161
25. + regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 180 (2008) 2747-2751
26. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., et al. IL-21 and TGF-β are required for differentiation of human Th17 cells. Nature 454 (2008) 350-352
27. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
28. Izcue A., Hue S., Buonocore S., Arancibia-Cárcamo C.V., Ahern P.P., Iwakura Y., et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28 (2008) 559-570
29. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 (2006) 929-936
30. Huber M., Steinwald V., Guralnik A., Brüstle A., Kleemann P., Rosenplänter C., et al. IL-27 inhibits the development of regulatory T cells via STAT3. Int Immunol 20 (2008) 223-234
31. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8 (2007) 380-389
32. Mennechet F.J., and Uzé G. Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107 (2006) 4417-4423
33. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007) 566-569
34. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37 (2007) 3021-3029
35. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 (2004) 1455-1465
36. + regulatory T cells from nonobese diabetic mice. J Immunol 175 (2005) 3053-3059
37. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199 (2004) 1467-1477
38. high regulatory T cells. Blood 104 (2004) 895-903
39. + regulatory T cells suppress effector T cell proliferation. Clin Immunol 115 (2005) 3-9
40. - cells. Proc Natl Acad Sci USA 102 (2005) 4103-4108